{"task_id": "4e4206d11b651e32", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 229/464)", "text": "invasion, treat as IA2\ndisease\n218\nCervical Cancer\n\n--- Page 240 ---\nSTAGE IA2, IB1\nradical hysterectomy, bilateral\npelvic and paraaortic lymphadenectomy\nSTAGE IB2, IIA\nchemoradiation with cisplatin \u0006\n5 FU. Alternatively, radical hysterectomy, bilateral\npelvic and paraaortic lymphadenectomy, followed by\nadjuvant radiation or chemoradiation with cispla\ntin \u0006 5 FU\nSTAGE IIB, III, IVA (locally advanced)\nchemoradia\ntion with cisplatin \u0006 5 FU \u0006 additional brachytherapy\nSTAGE IVB\npalliative chemotherapy (cisplatin\ntopotecan, cisplatin paclitaxel, cisplatin, carboplatin,\nbleomycin, mitomycin C), palliative radiation\nMANAGEMENT (CONT\u2019D)\nRECURRENCE\nfor locally recurrent disease, pelvic\nexenteration (32 62% 5 year survival). For recur\nrence in the pelvis following radical surgery, chemor\nadiation with cisplatin or 5 FU \u0006 mitomycin C\n(40 50% cure). If distant recurrence, treat with pal\nliative chemotherapy\nHPV VACCINATION\nmay offer primary prevention\nalthough clinical data lacking at this time. Current\nvaccines are created against common serologic types\nonly, including HPV 6, 11, 16, and 18\nCancer of Unknown Origin\nPATHOPHYSIOLOGY\nCLASSIFICATION BY HISTOLOGY\n\u0002\nADENOCARCINOMA\nwell to moderately differen\ntiated (60%)\n\u0002\nADENOCARCINOMA/CARCINOMA\npoorly\ndifferen\ntiated (30%)\n\u0002\nSQUAMOUS CELL CARCINOMA (5%)\n\u0002\nUNDIFFERENTIATED NEOPLASMS (5%)\nNATURAL\nHISTORY\nearly,\nunpredictable,\nand\naggressive metastasis. Primary too small to cause\nsymptoms\nRelated Topic\nTumor Markers (p. 220)\nIMMUNOHISTOCHEMICAL MARKERS\n\u0002\nCARCINOMA\ncytokeratin negative, common leuko\ncyte antigen, S100, vimentin negative. Breast can\ncer may be ER/PR positive\n\u0002\nLYMPHOMA\ncommon leukocyte antigen\nPATHOPHYSIOLOGY (CONT\u2019D)\n\u0002\nSARCOMA\nvimentin positive (mesenchymal), des\nmin positive (rhabdomyosarcoma), factor VII anti\ngen (angiosarcoma)\n\u0002\nMELANOMA\nS100, HMB 45, MART, vimentin, NSE\npositive\n\u0002\nNEUROENDOCRINE\nTUMORS\nneuron specific eno\nlase, synaptophysin, chromogranin\nINVESTIGATIONS\nBASIC\n\u0002\nLABS\nCBCD, lytes, urea, Cr, glucose, AST, ALT,\nALP, bilirubin, LDH, INR, PTT, b hCG, AFP, PSA, Ca\n125, CEA, CA 19 9\n\u0002\nIMAGING\nCT chest/abd/pelvis\n\u0002\nSPECIAL\ntissue biopsy\nMANAGEMENT\nTREAT UNDERLYING CAUSE\nsee table below for\ntailored treatment of cancer of unknown primary\nbased on most likely tumor type\nSUPPORTIVE\nsymptom control, consider palliative\ncare consult\nPresentation\nLikely primary\nKey history and physical Investigations\nEmpiric treatment(s)\nPoorly differentiated\nmidline disease in\nyoung men\nGerm cell tumor (testicular,\nretroperitoneal)\nGynecomastia suggests\nseminoma. Perform\ntesticular examination\nb-hCG, AFP. Look for\nisochromosome 12\nwhich suggests tumor\nresponsive to\nplatinum-based\ntherapy\nTreat as germ cell tumor (BEP).\nPotentially curable\nSquamous cell\ncarcinoma with\ncervical\nlymphadenopathy\nHead and neck cancer\n(hypopharynx,\noropharynx,\nnasopharynx), skin,\nesophagus, lung\nSmoker, alcohol use\nQuadroscopy, CT chest,\nPET scan.\nBronchoscopy and\nupper GI endoscopy\nmay be considered.\nFNA first, then core\nbiopsy if negative\nNeck dissection and radiation.\nPotentially curable\nAxillary\nlymphadenopathy\nin women\nBreast cancer\nBreast exam\nMammogram, U/S\nbreast, MRI breast\nMastectomy with axillary\ndissection or whole breast\nirradiation, adjuvant\nchemotherapy. If lytic\nmetastasis in post-\nmenopausal women, consider\nhormonal treatment\nMANAGEMENT (CONT\u2019D)\nCancer of Unknown Origin\n219", "text_length": 3368, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 229/464)", "type": "chunk", "chunk_index": 228, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.561997", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.562726", "status": "complete", "chunks_added": 2}